
Incontinence
Most Common Factor
Weak pelvic floor muscles causing stress incontinence, urge incontinence, and overactive bladder (OAB)
UTI and constipation commonly contribute, especially in older adults
Types:
Stress: Weak sphincters leading to leakage with increased intra-abdominal pressure (e.g., coughing, laughing)
Urge: Overactive bladder (OAB) with involuntary detrusor contractions ± weak sphincters
Overflow: Poor bladder emptying due to detrusor underactivity or bladder outlet obstruction
Differential Diagnosis: DIAPPEERSSS
Delirium/dementiaInfection
Infection - UTI / interstitial cystitis
Atrophic vaginitis
Psychl (neuro) - MS, stroke, parkinsons, spinal cord inj, depression
Pharmaceuticals (anticholinergic inc TCA, diuretics, sedatives, opioids)
Excess fluids/weight - Alcohol, caffeine, ↑ intra-abdominal pressure
Endocrine - Diabetes (polyuria), hyperCa (polyuria, weak bladder)
Restricted mobility
Stool impaction
Sphincter weakness (childbirth, pelvic organ prolapse)
Sphincter blockage (bladder stone/tumour, BPH, prostate cancer, urethral stricture, ovarian tumour)
History
Type
Stress: Worse with coughing, sneezing
Urge: Sudden, strong need to void ± leakage
Overflow: Incomplete emptying, dribbling
Storage symptoms: Frequency, urgency, nocturia
Voiding symptoms: Hesitancy, dribbling, incomplete emptying
Severity: Frequency, pad use, impact on QoL
Key History Questions to Differentiate Causes
Dysuria
Haematuria
Vaginal dryness / postmenopausal
Medication use
Etoh/caffeine intake
Restricted mobility
Constipation
Previous childbirths, prolapse
Weight loss
Previous prostatic surgery
Family history prostate ca
Bone pain
Incomplete emptying
Additional Considerations
Anticholinergics: Increase muscle relaxation → may worsen overflow incontinence, especially in neurological patients (e.g., Parkinson’s, dementia)
Urge incontinence → Often from bladder irritation (e.g., stones, infection, malignancy, atrophic vaginitis)
Examination
General Exam:
BMI: Obesity → Stress incontinence risk
Abdomen: Palpable bladder → Chronic retention, mass if suprapubic fullness
Neurological (Lower Limbs & Perineum): Assess for spinal cord pathology, MS, stroke
Women:
Pelvic exam: Atrophic vaginitis, pelvic organ prolapse
Pelvic floor strength: Ask patient to contract muscles
Cough test: Observe for stress incontinence
Men:
Genital exam: Phimosis, narrow meatus
DRE: Prostate size, consistency (BPH, malignancy)
Investigations:
US for KUB and PVR (>100mL abnorm)
Urine MCS
Bladder diary
Fasting BSL
eGFR (assess kid inj, more in men if susp retention)
STI screen
PSA
Key Notes:
Pelvic organ prolapse & atrophic vaginitis → Assess in women
PVR is crucial for differentiating overflow incontinence
Neurological causes → Consider in abnormal lower limb reflexes/perineal sensory loss
Bladder diary helps distinguish urge, stress, mixed, and overflow incontinence
Management
Non-Pharmacological
Bladder diary to identify patterns and triggers
Bladder training / timed voiding to increase bladder capacity and reduce urgency
Avoid excessive fluid intake, especially after midday
Avoid bladder diuretics (e.g., caffeine, alcohol) that increase urine production
Avoid bladder irritants (e.g., spicy foods, artificial sweeteners, carbonated drinks)
Pelvic floor exercises (e.g., Kegel exercises) to strengthen muscles and improve control
Maintain regular soft bowel motions with a high-fibre diet to prevent constipation, which worsens incontinence
Weight loss in overweight/obese patients to reduce intra-abdominal pressure and symptom severity
Smoking cessation as smoking worsens incontinence via chronic cough and bladder irritation
Pharmacological
Anticholinergics: Oxybutynin (patch formulation reduces dry mouth), solifenacin
Beta-adrenergic agonists: Mirabegron (useful in overactive bladder, fewer cognitive side effects than anticholinergics)
Vaginal oestrogens: Estradiol pessaries (limited evidence, but may improve urogenital atrophy in postmenopausal women)
Note: Laser ablation/resection of the prostate is as effective as TURP and may have fewer complications in selected patients
Benign Prostatic Hyperplasia (BPH) and Incontinence
All the above non-pharmacological strategies can be used for BPH-related incontinence
Mild BPH (IPSS <7): Non-pharmacological management alone may be sufficient
Alpha-blockers:
Tamsulosin, prazosin (risk of postural hypotension, dizziness, erectile dysfunction)
5-alpha reductase inhibitors:
Dutasteride (can cause erectile dysfunction, reduced libido)
Combination therapy (tamsulosin + dutasteride = Duodart) for moderate to severe symptoms
Anticholinergics (e.g., oxybutynin, solifenacin) may be used in select cases with overactive bladder symptoms
Note: Consider using the International Prostate Symptom Score (IPSS) to guide management
Bookmark Failed!
Bookmark Saved!